Back
Worthington Enterprises Vs. Biomarin Pharmaceutical Industry Stock Comparison
Sell
26
WOR
Worthington Enterprises
Last Price:
41.79
Seasonality Move:
2.96%
Sell
32
BMRN
Biomarin Pharmaceutical
Last Price:
68.99
Seasonality Move:
7.09%
Sell
26
Worthington Enterprises (WOR)
is a Sell
Is Worthington Enterprises a Buy, Sell or Hold?
- The current Worthington Enterprises [WOR] share price is $41.85. The Score for WOR is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
- WOR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
32
Biomarin Pharmaceutical (BMRN)
is a Sell
Is Biomarin Pharmaceutical a Buy, Sell or Hold?
- The current Biomarin Pharmaceutical [BMRN] share price is $69.51. The Score for BMRN is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- BMRN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
WOR Stock Price Chart
What is Worthington Enterprises's stock price today?
-
The Worthington Enterprises share price today is $41.85
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and WOR is experiencing slight buying pressure.
BMRN Stock Price Chart
What is Biomarin Pharmaceutical's stock price today?
-
The Biomarin Pharmaceutical share price today is $69.51
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing buying pressure, which is a positive indicator for future bullish movement.
WOR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.03 | Sell |
Relative Strength Index (14 RSI): | 42.4 | Sell |
Chaikin Money Flow: | 83503 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (41.64 - 45.28) | Sell |
Bollinger Bands (100): | (43.06 - 53.14) | Sell |
BMRN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -4.27 | Sell |
Relative Strength Index (14 RSI): | 30.29 | Sell |
Chaikin Money Flow: | 1220572 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (68.28 - 84.92) | Sell |
Bollinger Bands (100): | (75.4 - 88.56) | Sell |
WOR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 41.32 | Buy |
20-day SMA: | 43.37 | Sell |
50-day SMA: | 44.62 | Sell |
200-day SMA: | 53.68 | Sell |
8-day EMA: | 41.87 | Sell |
20-day EMA: | 42.96 | Sell |
50-day EMA: | 44.78 | Sell |
200-day EMA: | 51.91 | Sell |
BMRN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 69.69 | Sell |
20-day SMA: | 73.65 | Sell |
50-day SMA: | 82.42 | Sell |
200-day SMA: | 85.51 | Sell |
8-day EMA: | 69.95 | Sell |
20-day EMA: | 73.68 | Sell |
50-day EMA: | 79.12 | Sell |
200-day EMA: | 84.31 | Sell |
Worthington Enterprises Earnings Growth & WOR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.86 per share, and a decrease next year of $0.76 per share.
Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.19 per share, and an increase next year of $1.04 per share.
Worthington Enterprises Technical Analysis
Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | Oct | |||||||||
23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Biomarin Pharmaceutical Technical Analysis
Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | Oct | |||||||||
23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |